In another system, similar opposing effects of the CB1 receptor (as a tumor suppressor) to GPR55 (as an oncogene) have been documented, in which DNA methylation of the CNR1 and GPR55 genes were also differentially regulated in samples from patients with colorectal cancer compared to control samples [63]. The gene discussed is GPR55; the disease is colorectal cancer.